Search

Your search keyword '"Silvia Grottoli"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Silvia Grottoli" Remove constraint Author: "Silvia Grottoli"
188 results on '"Silvia Grottoli"'

Search Results

1. Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature

2. Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study

3. Isolated anterior pituitary dysfunction in adulthood

4. MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis

5. A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score

6. Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests

7. Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment

8. Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis

9. Strumenti per la lettura critica di metanalisi e revisioni sistematiche: il punto di vista del clinico

10. Attuali applicazioni della determinazione dei livelli plasmatici di copeptina in contesti non-endocrinologici

11. Adrenocortical, somatotropic and antidiuretic response to nasal glucagon in healthy subjects

12. Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands

13. Validation of a clinicopathological prognostic score for elderly patients undergoing endoscopic endonasal surgery for pituitary adenoma: a single center 10 years’ experience and review of the literature

15. Le neoplasie associate a feocromocitoma/paraganglioma in quadri SDHx positivi o negativi: adenomi ipofisari, tumori stromali gastro-intestinali e tumori renali

16. Obesità post-neurochirurgia ipotalamica

17. Morning Serum Cortisol Level Predicts Central Adrenal Insufficiency Diagnosed by Insulin Tolerance Test

18. Impact of COVID-19 lockdown in patients with acromegaly: an Italian multicenter experience

25. Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study

26. Primary Pituitary Lymphoma As Rare Cause Of A Pituitary Mass And Hypopituitarism In Adulthood

27. The Cut-off Limits of Growth Hormone Response to the Insulin Tolerance Test Related to Body Mass Index for the Diagnosis of Adult Growth Hormone Deficiency

28. Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives

30. Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

31. Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests

34. Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study

36. Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH–and GH-secreting pituitary neuroendocrine tumor (PitNETs) cell lines

37. Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment

38. First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence

39. Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment

40. Treatment of acromegalic osteopathy in the real-life clinical practice: The baac (bone active drugs in acromegaly) multicenter study

41. Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH- and GH-secreting pituitary neuroendocrine tumor cell lines

43. Pituitary surgery during Covid-19: a first hand experience and evaluation

44. Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients

45. Surgical management of pituitary adenomas: does age matter?

46. Treatment of acromegalic osteopathy in real-life clinical practice: The BAAC (bone active drugs in acromegaly) study

47. Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication?

48. The prevalence of silent acromegaly in prolactinomas is very low

49. The Effects of Altitude on the Hormonal Response to Physical Exercise

50. Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy

Catalog

Books, media, physical & digital resources